Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Planned sale President, R&D sold 93,456 shares at $16.94 ($1,583,145)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Planned sale Chief Financial Officer sold 17,717 shares at $12.86 ($227,841)
  10. 4 Open-market sale Chief Financial Officer sold 972 shares at $14.79 ($14,376)
  11. 4 Open-market sale See remarks sold 753 shares at $14.79 ($11,137)
  12. 4 Open-market sale President, R&D sold 1,490 shares at $14.79 ($22,037)
  13. 4 Planned sale Chief Financial Officer sold 19,517 shares at an average $13.19 ($257,498)
  14. 4 Planned sale Chief Financial Officer sold 17,717 shares at $10.06 ($178,233)
  15. 4 Open-market sale President, R&D sold 21,581 shares at an average $7.72 ($166,677)
  16. 4 Open-market sale See remarks sold 13,038 shares at an average $7.71 ($100,473)
  17. 4 Open-market sale Chief Financial Officer sold 15,515 shares at an average $7.71 ($119,631)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 16 · 320 filings